Clinical trial
Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
NCT06283524 is registered in ClinicalTrials.gov with Innodem Neurosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Eye-tracking Investigation of Clinical Measures in Multiple Sclerosis
- Lead sponsor
- Innodem Neurosciences
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 18, 2024
- Completion date
- March 18, 2026
- Enrollment
- 200 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.